Calderasib (MK-1084) is an orally available inhibitor of the oncogenic KRAS substitution mutation G12C, with potential antineoplastic activity.
For research use only. We do not sell to patients.
| Name | Calderasib ( MK-1084 ) |
|---|---|
| Iupac Chemical Name | 19-chloro-22-[(2S,5R)-2,5-dimethyl-4-prop-2-enoylpiperazin-1-yl]-13,16-difluoro-3-propan-2-yl-8,11-dioxa-1,4,23,26-tetrazapentacyclo[16.6.2.02,7.012,17.021,25]hexacosa-2(7),3,5,12,14,16,18,20,22,25-decaen-24-one |
| Synonyms | Calderasib ; MK-1084 ; MK1084 ; MK 1084 |
| Molecular Formula | C32H31ClF2N6O4 |
| Molecular Weight | 636.21 |
| Smile | O=C1N=C(N2[C@@H](C)CN(C(C=C)=O)[C@H](C)C2)C3=CC(Cl)=C4C5=C(F)C=CC(F)=C5OCCOC6=C(C(C(C)C)=NC=C6)N1C3=N4 |
| InChiKey | BBIVCWWQPMOKAC-MSOLQXFVSA-N |
| InChi | InChI=1S/C32H31ClF2N6O4/c1-6-24(42)39-14-18(5)40(15-17(39)4)30-19-13-20(33)27-25-21(34)7-8-22(35)29(25)45-12-11-44-23-9-10-36-26(16(2)3)28(23)41(31(19)37-27)32(43)38-30/h6-10,13,16-18H,1,11-12,14-15H2,2-5H3/t17-,18+/m1/s1 |
| CAS Number | 2641216-67-1 |
| Related CAS | 2641216-67-1 |
| Packaging | Price | Availability | Purity | Shipping Time |
|---|---|---|---|---|
| Bulk | Enquiry | Enquiry | Enquiry |
| Formulation | Off-white solid |
|---|---|
| Purity | ≧98.0% |
| Storage | Dry, dark and at 0 - 4℃ for short term (days to weeks) or -20℃ for long term (months to years). |
| Solubility | Soluble in DMSO (DMSO : ≥ 100 mg/mL) |
| Handling | Refer to MSDS |
| Shipping Condition | Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs. |
| HS Code | 2934200090 |
| Targets | |
|---|---|
| Mechanism | |
| Cell study | |
| Animal study | |
| Clinical study |